Sep 2026· Naunyn-Schmiedeberg's Archives of Pharmacology· 0 citations· 21 references
Medicine
TL;DR
Collectively, TRIM28 facilitates DLBCL progression by inducing glycolytic reprogramming through the E2F1/PKM2 axis, highlighting a potential therapeutic target.
Introduction LINC00887 plays critical roles in tumor biology, from oncogenesis to metastasis and drug resistance, while the specific mechanism in ccRCC remains unclear. We analyzed the expression profiles of LINC00887 and UPF1 and assessed their correlation with glycolytic activity and M2 macrophage infiltration. Metho...
Jia-Yue Wu, Jia-Wen Wang, Jing-Yu Weng et al.· Frontiers in Immunology· 0 citations
Dysregulated lipid metabolism is a core hallmark of diffuse large B-cell lymphoma (DLBCL), while the upstream non-coding RNA regulatory network targeting sphingosine kinase 1 (SPHK1), a key lipogenic kinase, remains largely uncharacterized in DLBCL. Here, we identified and validated a novel ceRNA regulatory axis co...
Abstract Background Doxorubicin, an anthracycline chemotherapeutic agent, is widely used in diffuse large B‑cell lymphoma (DLBCL) treatment, yet its clinical efficacy is often compromised by drug resistance. Protein arginine methyltransferase 7 (PRMT7) is a methyltransferase implicated in tumourigenesis and cancer prog...
Xiao-Yan Zhao, J. Zhang, Yao Teng et al.· Clinical and Translational M...· 0 citations
Triple-negative breast cancer (TNBC) presents significant clinical challenges due to its aggressive phenotype and the limited availability of molecularly targeted therapies. In this study, we investigated the therapeutic potential of targeting PHB2 in TNBC by combining bioinformatics analysis with comprehensive in vitr...
Zan-Kai Wu, Shan-Shan Wang, Qing-Feng Yang et al.· Carcinogenesis· 0 citations
These results uncover a metabolism-epigenetics–cell cycle interface that may represent a therapeutic vulnerability in EGFR-mutant LUAD and identify a glycolysis–H4K8la–GAS2L3 axis that drives noncanonical cell-cycle reprogramming independently of classical Cyclin–CDK activation, thereby promoting acquired osimertinib r...
Shu-Man Zhen, Xiaohui Bai, Shu-Tang Liu et al.· Cell Death Discovery· 0 citations
Clear cell renal cell carcinoma (ccRCC) is characterized by glycolytic reprogramming and a lactate-rich tumor microenvironment. We integrated multi-omics, single-cell, tissue microarray, and in vitro analyses to investigate the roles of Glut1 and MCT4 in ccRCC. Both transporters were upregulated at the mRNA and protein...
Kun Cui, Yu-Zhi Zhu, Yue-Li Ni et al.· Biochemical and Biophysical...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.